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Myosin light chain kinase (MLCK) contains the autoinhibitor sequence right next o the N-terminus side of the ealrnodulia binding region. In this 
paper, the structural requirement of the inhibition of MLCK activity was studied using synthetic peptide analogs. Peptides Ala-783-Lys-799 and 
Ala-783-Arg-798 inhibited ealmodulin i dependent MLCK at the same potency as the peptide Ala-783-Gly-804. Deletion of Arg-797-Lys-799 or
substitution of these residues to Ala markedly increased the /f~ while the substitution of Lys-792 and Lys-793 to Ala and the deletion of 
Lys-784--Lys-785 did not affect the inhibitory activity o1" the peptides. The results uggest that Arg-797-Arg-798 are especially important for the 
inhibitory activity among other basic residues in the autoinhibitory egion. 
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1. INTRODUCTION 
Activation of contractile machinery of smooth mus- 
cle is triggered b), phosphorylation f the regulatory 
light chain of myosin [1,2]. Phosphorylation f the reg- 
ulatory light chain of myosin is catalyzed by a Ca~-*/ 
calmodulin-dependent myosin light chain kinase 
(MLCK). The structure-function relationships of 
smooth muscle MLCK are greatly assisted by the deter- 
mination of the complete amino acid sequence [3-5]. In 
the central portion of the molecule, the sequences com- 
monly observed in various protein kinases [3-5] are 
found and, therefore, it is assigned that the catalytic 
domain exists at the central part of the molecule. Cal- 
modulin binding peptide was isolated by Lukas et al. [6] 
and the sequence correlates with residues 797-816 of 
chicken gizzard MLCK sequence [3,4] which lies to- 
wards the C-terminal side of the catalytic domain. 
Kemp et al. [7] found that residues 788-811 showed 
significant homology to the N-terminal sequence of the 
regulatory light chain of myosin and that a synthetic 
peptide analog of this region inhibited Ca2÷/calmodulin - 
dependent MLCK activity. Based upon this result, 
Kemp et al. [7] proposed that this region serves as a 
pseudo-substrate inhibitor. We demonstrated [8] that 
the proteolysis of the kinase yielded a 64 kDa inactive 
fragment which was converted to a 61 kDa active Ca2*/ 
calmodulin-independent ki ase by further proteolysis. 
The Ca2"/calmedulin-independent MLCK in which the 
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regulatory site is removed was strongly inhibited by the 
pseudo-substrate inhibitor peptide residues 783-804 [8]. 
These results show that there is an autoinhibitory do- 
main at the N-terminal side of the calmodulin binding 
region. However, it is controversial whether or not the 
autoinhibitory domain functions as a pseudo-substrate 
inhibitor. Recent studies on skeletal muscle and non- 
mmele myosin light chain kinas¢ suggested [9,10] that 
the inhibitory region may not simply function as a 
pseudo-substrate inhibitor. 
In this paper, the structure required for the autoinhib- 
ition of smooth muscle MLCK was studied using vari- 
ous synthetic peptide analogs of the autoinhibitory do- 
main of MLCK. The obtained information of the struc- 
tural requirement of the peptide inhibitor is directly 
relevant to in rive application to study the physiological 
function of the kinase [11] and this is another objective 
of this paper. 
2. MATERIALS AND METHODS 
2,1. Proteim' and pepttdes 
MLCK [8] and calmodulin [12] were prepared from turkey gizzard 
and bull testes, respectively, Constitutively active MLCK was ob- 
tained by tryptic dig~tion of MLCK as described previously [8]. 
Smooth muscle CaMPKII was prepared from chicken gizzard as de- 
scribed previously [13]. Smooth muscle S.l was prepared from turkey 
gi:~ard myosin [14] by S. aureus pretense digestion as described previ- 
ously [15]. Caldesmon was prepared from turkey l~izzard according to 
the method of Bretcher [16], 
2.2, Others 
Pb.osphorylation F proteins war, assayed as described by Walsh ct 
al. [I 2]. Protein concentration was estimat~ by biuret or spectromet- 
ric measurements forealmodulin E277~m = 1.9; MLCK, E~m = 1 !.4. 
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3. RESULTS AND DISCUSSION 
It has been found [17] that the amino acid sequence 
at the N-terminal side of the regulatory site of MLCK 
is homologous to the sequence at the N-terminal side of 
the phosphorylation site of the regulatory light chain of 
myosin in terms of their abundance ofbasic amino acid 
residues. Based upon this finding, it was proposed [7,17] 
that this basic amino acid rich region may act as a 
pseudo-substrate inhibitor. We synthesized various yn- 
thetic peptid¢ analogs of the inhibitory region of 
smooth muscle MLCK (Table I) and studied the re- 
quirement of basic amino acid residues for the inhib- 
itory activity. The basic amino acid residues of the in- 
hibitory region analog peptide were either deleted or 
substituted for alanine (Table I). Fig. 1 shows the inhi- 
bition of the Ca-'÷/calmodulin-independent constitu- 
tively active MLCK activity by synthetic peptide ana- 
logs. The peptides Leu-786-Lys-802 and Lys-788-Lys- 
799 inhibited the constitutively active MLCK with a 
similar potency to the peptide Ala-783-Gly-804. This 
suggests that a cluster of the basic amino acid residues 
Lys-784 and Lys-785 are not essential for the inhibitory 
activity of the peptides. The results also suggest that the 
C-terminal side of the cluster of basic amino acid resi- 
dues, Trp-800-Gly-804, are not important for the inhib- 
itory activity. Substitution of Lys-792 and Lys-793 did 
not significantly alter the inhibitory activity of the pep- 
tides suggesting that these basic amino acid residues are 
not important for the inhibitory activity of the peptides. 
On the other hand, both deletion of a cluster of the basic 
amino acid residues, Arg-797-Lys-799, and substitution 
of Arg-797-Lys-799 for alanine significantly decreased 
the inhibitory activity of the peptides. To further ana- 
lyze the importance of these residues, a single amino 
Table 1 
Structure of the inhibitory peptide~ and their K~ against MLCK, 
IMLCK" and CaMPKII 
Peptides ~ ~M)  b 
IMLCK MLCK' CaMPKIF 
783 804 
AKKLSKDRMKKYMARRKWQKTG 0.075 0.114 1.09 
LSKDRMKKYMARRKWQK 0.060 0.I I0 1.05 
AKKL SKDIR~.MKKYMARRK 0.063 0.100 6.60 
AKKL $KDF, MKKY.'CARR 0.034 O, 1 O0 8.60 
KDRMKKYb~RR O. I 15 0.302 4.37 
AF.KLSKDRMAAYMARRR 0.105 - - 
AKKLSKDRMKKYMA 3.000 - - 
AKKLSKDRblRRYMAAAA 3.600 - - 
"Constitutively active MLCK. 
b Ki was estimated by measuring the kinase activity as a function of the 
inhibitory peptid¢ concentration. Conditions are the same as Fig. 1. 
' Assay was done in the presence of 0.1/aM calmodulin and 0.2 mM 
CaCI2; otherwise the same as in Fig. 1. CaMPKII activity was meas- 
u~d mine caldgsnton ~ a substrat¢. 
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Fig. 1. Inhibition of constitutively active MLCK by the synthetic 
peptide analogs of autoinhibitory domain. 0.5/ag/ml of constitutively 
active MLCK was incubated with the synthetic peptides in the pres- 
ence of I mM MgCla, 1 mM EGTA, 30 mM NaCI, 0.26 m~ml smooth 
muscle S.I and 30 mM Tris-HCI, pH 7.5, at 25°C for 5 rain. The 
phosphorylation reaction was started by adding 0.2 mM [7-~"P]ATP. 
The activity was estimated from the initial linear phase of the phos- 
phorylation time course. The inhibition ot" the kinase activity in the 
presence of peptides was expressed by taking the activity in the absence 
of the peptides as 1.0. (o) peptide Ala-783-Giy-804; (a) peptide Ala- 
783-Lys-799; (r~) peptide Ala-783-Lys-799 in which Lys-792 and Lys- 
793 are substituted for Aim (•) peptide Lys-TSS-Lys-799; (m) peptide 
Ala-783-Arg-798; (4) peptide Ala-783-Lys-799 in which Arg-797, 
Ar~-798, and Lys.799 are substituted for Ala; (v) peptidc Ala-783- 
Lys-796. 
acid residue of Lys-799 was deleted and the effects of 
the deletion on the inhibitory activity were examined. 
However, the deletion of Lys-799 did not decrease the 
inhibitory activity of the peptide. These results uggest 
that Arc-797 and Arc-798 are important for the inhib- 
itory activity of the peptide, while other basic amino 
acid residues in the inhibitory region of MLCK are not 
essential for the inhibitory activity. It was shown [18] 
that the peptide Asp-777-Lys-793 has little inhibitory 
activity against he constitutively active MLCK with a 
Ki of 140 gM. Therefore, although the significance of 
Lys-788 and Arg-800 on the inhibitory activity was not 
directly determined, it is unlikely that these residues 
significantly contribute to the inhibitory activity of the 
peptides. It should be noted, however, it was shown [8] 
that the peptide Ala-796--Ser-815 which contains a clus- 
ter of basic amino acid residues Arg-797-Lys.799 is not 
a strong inhibitor for Ca2*/calmodulin-independent 
MLCK suggesting that the amino acid residues Arg- 
797-Arc-798 are important but not sufficient to express 
the inhibitory activity. The N-terminal side structure of 
Arg-797-Arg-798 is also ,.o~;,;,°A r,~, h° ;.,~;h;, .... 
tivity. The importance of the basic amino acid residues 
in the autoinhibitory egion for the inhibitory activity 
was originally pointed out by Kemp and co-workers [7]. 
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Because of the similarity between the autoinhibitory 
region and the myosin light chain phosphorylation site 
in terms of a cluster of basic residues, Kemp et al. [7] 
proposed that the autoinhibitory region acts as a 
pseudo-substrate inhibitor. Based on the substrate spec- 
ificity studies using synthetic peptidv analogs of the 
myosin light chain phosphorylation site, it was shown 
[17] that the basic residues in the light chain which 
correspond to Lys-788, Are-790, Lys-792, Lys-793o 
Arg-797, Arg-798, Lys-799 and Lys-802 of the inhib- 
itory region are important for substrate recognition and 
among them the last four residues are more important. 
A present study showed that Arg-797 and Arg-798 were 
important for the inhibitory activity but other basic 
residues were not essential for the inhibitory activity. 
This is distinct from the suggestion made by previous 
reports [7,18]. It has been shown that Arg-I 3 and Arg- 
16 of the regulatory light chain of smooth muscle 
myosin which correspond to Lys-799 and Lys-802 of 
MLCK are necessary for the substra~.e r~ognidon of 
MLCK using synthetic peptide analogs [17] and trun- 
cated regulatory light chain [19]. This suggests that the 
inhibition of the kinase by the autoinhibitory egion is 
not due to the simple pseudo-substrate m chanism. 
Recently, it was reported [10,20] that the substitution 
of Arg-797-Lys-799 with glutamic acid residues by site- 
directed mutagenesis did not produce Ca~+/calmodulin - 
independent kinase activity. This suggests hat although 
Arg-797-Arg-798 are important for the inhibition of 
MLCK, the residues in the upstream of the autoinhib- 
itory region also contribute to the inhibition of the ki- 
nas¢ when the autoinhibitory egion is incorporated in
MLCK. Shoemaker et al. [10] reported that the substi- 
tution of the six basic residues of (Lys-783, -784, -788, 
-792, -793 and Arg.790) the upstream part of the auto- 
inhibitory region with glutamic acid produced Ca2+/ 
ealmodulin-independent activity. It was also suggested 
[21] that the cleavage at the N-terminal side of the clus- 
ter of the three basic residues, i.e. at the C-terminus of 
Arg-797 or Lys-792, produced an inactive form of 
MLCK which was converted to a constitutively active 
form by further proteolysis. This suggests that in the 
native protein, the N-terminal side of the autoinhibitory 
region may be important for the depression of enzyme 
activity although Arg-797 and Arg-798 may be also 
important for the inhibition of the activity. 
Another interesting point for understanding the 
structure required for the regulation of MLCK is the 
structure required for ealmoduiin binding. We meas- 
ured the attenuation of the inhibitory activity of the 
pvptides by ealmodulin to evaluate the calmodulin bind- 
ing activity of the poptidvs (Fig. 2). Consistent with the 
earlier eport [8], the inhibitory activity of the peptide 
Ala.7$3-G!y-804 was reversed by calmodulin, Deletion 
of Trp-800-Gly-804 decreased the caimodulin binding 
activity; however, significant calmodulin binding activ- 
ity was still observed. Although the calmodulin binding 
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Fig. 2. ElYect of calmodulin on the inhibition of constitutively active 
MLCK by the synthetic peptide analogs of autoinhibitory domain. 
Assay was done as d~zcribed in Fig. 1. except 0.2 mM CaCI_~ and 
various conc, ntrations of ¢almodulin were added insteaa of I mM 
EGTA. (o) 0.5 ,aM peptide Ala-783-Gly-804; (A) 0.5 gM Ixptide 
Ala-783-Lys-799; (o) 0.5 #M peptide Ala.783-Arg-798. 
activity was a little decreased, eletion of an additional 
Lys-799 did not abolish the caimodulin binding activity. 
These results uggest that the calmodulin binding region 
and the autoinhibitory e~ion overlap. Consistent with 
this result, the peptides also inhibited smooth muscle 
CaMPKll although a higher concentration was re- 
quired for the inhibition (Table I). The inhibitory activ- 
ity of these peptides against CaMPKI[ coincided with 
the calmodulin binding activity (Fig. 2); therefore, the 
inhibition is likely to be due to tile calmodulin binding 
activity of the peptides. Actually the apparent Ki for the 
inhibition of CaMPKII by the peptides increased at 
higher calmodulin concentration (data not shown). Re- 
cently, Bagchi et al. [20] reported by analyzing the cal- 
modulin binding to the mutant MLCK that the substi- 
tution of Lys-802, Arg-798-Lys-799 with alanine atten- 
uates the calmodulin binding. The present results are 
consistent with their finding. The decrease in the affinity 
of the peptides tbr calmodulin by the deletion of the 
C-terminal side of the peptides is ~lso consistent with 
the recent analysis of calmodulin-skeletai MLCK p~p- 
tide complex by NMR which found that Trp-$00 is 
important for the hydrophobic interaction between 
calmodulin and MLCK and the basic residues possibly 
contribute to the electrostatic nteraction between cal. 
modulin and MLCK [22]. 
Another significanc~ of this study is to develop the 
specific peptide inhibitor of MLCK. We previously re. 
ported [1 I] that the peptide inhibitor of MLCK (resi- 
dues 783-804) inhibits the contraction of the isolated 
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single smooth muscle cells after the high K+-induced 
stimulation although the transient increase in the cyto- 
plasmic Ca :+ after the stimulation is rather increased by 
the peptide injection. As shown in Table I, although 
higher concentration was required the peptide Ala-783- 
Gly-804 also inhibited CaMPKII. Since MLCK is 
thought to be a quite substrate-specific kinase and 
known substrate is only the regulatory light chain of 
myosin while CaMPKII is known to have a broad sub- 
strate specificity, it is likely that the observed enhance- 
merit of the transient increase in the cytoplasmic Ca ~-~ 
is likely to be due to the inhibition of CaMPKII by the 
peptide. The truncation of the C-terminal side of the 
peptide decreased the calmodulin binding activity (Fig. 
2), therefore, it is expected that the shorter peptides such 
as Ala-783-Arg-798 serve as a more specific inhibitor. 
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